Life sciences · Journal article
Virulence · September 11, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Escherichia coli K1 (E. coli K1) meningitis develops after the bacteria cross the blood-brain barrier (BBB); however, the molecular mechanisms underlying this process remain incompletely understood. Adhesion to human brain microvascular endothelial cells (HBMECs), which constitute the BBB, is considered important in E. coli K1 bacterial penetration into the central nervous system. Here, we report a complete signal regulatory pathway in which the ZraSR two-component system (TCS) senses mechanical cues-specifically, physical forces and envelope perturbations generated by the initial attachment of E. coli K1 to host cells-and directly binds to fimS, the invertible promoter element of the fim operon (fimAICDFGH). This interaction promotes fimS inversion to the phase-ON orientation, thereby activating the expression of type 1 fimbriae, specifically the FimH adhesin. This activation enhances E. coli K1 invasion into HBMECs. Disruption of this signaling pathway severely attenuates the progression of meningitis and reduces the production of proinflammatory factors triggered by E. coli K1 infection in vivo. These findings suggest that components of this pathway may serve as potential targets for novel therapeutic strategies against E. coli K1 infection.